{"nct_id":"NCT00115219","title":"Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)","status":"COMPLETED","status_verified_date":"2013-05","start_date":"2005-05","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":null,"completion_date_type":null,"phases":["PHASE4"],"tickers":["AMGN"]}